Clinical Trial Update: Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China

View source ↗

Summary

GlaxoSmithKline-sponsored study in China evaluating chronic obstructive pulmonary disease phenotypes and endotypes has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2025-08-20